Kairos Pharma, Ltd. Share Price
NASDAQ: KAPA
Live Kairos Pharma, Ltd. Share Price Chart
O H L
Kairos Pharma, Ltd. Performance Overview
Days Range
▼
$1.78Low
$1.80High
Markets Today
| Previous Close | $1.81 |
|---|---|
| Open | $1.78 |
| Volume | 29,378 |
| Day's Range | $1.78 - $1.80 |
| 52W Range | NA |
| Market Cap | $6.13 M |
Historical Performance
| 1M Returns | -16.64 |
|---|---|
| 3M Returns | -39.87 |
| 6M Returns | -57.47 |
| 1Y Returns | -80.70 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Kairos Pharma, Ltd. Fundamentals
| Market Cap | $6.13 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-3.24 M |
| Profit Margin | N/A |
| Market Cap | $6.13 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-3.24 M |
| Profit Margin | N/A |
Kairos Pharma, Ltd. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$1.27 M | -$1.46 M | -$1.44 M | -$1.42 M | -$1.69 M | -$1.42 M |
| EBITDA | -$1.23 M | -$1.42 M | -$2.69 M | $795.00 K | -$1.43 M | -$1.61 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $40.00 K | $40.00 K | -$1.26 M | $2.21 M | $260.00 K | -$198.00 K |
| Income Before Tax | -$1.26 M | -$1.42 M | -$1.40 M | -$1.36 M | -$1.65 M | -$1.39 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$1.26 M | -$1.42 M | -$1.40 M | -$1.36 M | -$1.65 M | -$1.39 M |
| Net Profit Margin | - | - | - | - | - | - |
Kairos Pharma, Ltd. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $500.00 K | $18.00 K | $21.00 K | $21.00 K | $21.00 K | $21.00 K |
| Reserve & Surplus | -$10.08 M | -$11.50 M | -$12.90 M | -$14.26 M | -$15.92 M | -$17.30 M |
| Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Liabilities | $805.00 K | $676.00 K | $402.00 K | $199.00 K | $431.00 K | $265.00 K |
| Total Liabilities | $805.00 K | $676.00 K | $402.00 K | $199.00 K | $431.00 K | $265.00 K |
| Fixed Assets | $182.00 K | $142.00 K | $102.00 K | $62.00 K | $22.00 K | $0 |
| Current Assets | $6.05 M | $4.84 M | $6.66 M | $5.39 M | $4.44 M | $3.17 M |
| Total Assets | $7.94 M | $6.67 M | $8.07 M | $6.54 M | $5.74 M | $4.46 M |
Kairos Pharma, Ltd. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$1.26 M | -$1.42 M | -$1.40 M | -$1.36 M | -$1.65 M | -$1.39 M |
| Operating Cash Flow | -$714.00 K | -$805.00 K | -$838.00 K | -$1.08 M | -$1.04 M | -$1.01 M |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $3.06 M | $223.00 K | $3.38 M | $0 | $220.00 K | -$37.00 K |
| Change in Cash | $2.34 M | -$582.00 K | $2.54 M | -$1.08 M | -$816.00 K | -$1.05 M |
Kairos Pharma, Ltd. Return Calculator
The Kairos Pharma, Ltd. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Kairos Pharma, Ltd.
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.
Popular Stocks
FAQs
What is the share price of Kairos Pharma, Ltd. today?
Kairos Pharma, Ltd. (KAPA) share price as of September 18, 2026 is $1.71. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Kairos Pharma, Ltd.?
Yes, Indian Investors can invest in the Kairos Pharma, Ltd. (KAPA) Share by opening an international trading account with Angel One.
How can I purchase Kairos Pharma, Ltd. shares in India?
Purchasing Kairos Pharma, Ltd. (KAPA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Kairos Pharma, Ltd. (KAPA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Kairos Pharma, Ltd.?
Yes, you can purchase fractional shares of Kairos Pharma, Ltd. (KAPA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Kairos Pharma, Ltd.?
The market capitalization of Kairos Pharma, Ltd. on September 18, 2026, is $6.13 M.
In which sector Kairos Pharma, Ltd. belongs?
Kairos Pharma, Ltd. operates in the null sector, specifically in the null industry.
What documents are required to invest in Kairos Pharma, Ltd. stocks?
In order to invest in Kairos Pharma, Ltd. (KAPA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
